ScholarIQanswers from OpenAlex

Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy

PaperCitations, authors & open-access status

Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy have?

ScholarIQcitation count

Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy published?

ScholarIQyear

Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy has 2020 year in the ScholarIQ index.

What is the open-access status of Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy?

ScholarIQoa status

Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy has closed oa status in the ScholarIQ index.

What is the DOI of Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy?

ScholarIQdoi

The DOI for Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy is on the source record.

What is the OpenAlex record for Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy?

ScholarIQopenalex

The OpenAlex for Positive Circumferential Resection Margin Rates for Rectal Cancer in the US Remain Persistently High Despite Multimodality Therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial